The UAE has approved Foundayo (orforglipron), Eli Lilly’s once-daily oral obesity pill, becoming one of the first countries globally to offer a needle-free alternative. This GLP-1 receptor agonist mimics natural hormones to regulate appetite and blood sugar, aiding weight loss and improving metabolic health. Available by prescription from May 2026, it’s intended for long-term use alongside lifestyle changes.
Trending
- ‘Govt taking away their power’ vs ‘Why Rajiv Gandhi opposed’: Rahul–Rijiju clash over OBCs during women’s quota–delimitation debate
- ‘Leader of my party is not here’: Raghav Chadha takes veiled dig at Aam Aadmi Party in Rajya Sabha
- ‘Can’t be condemned enough’: Rajnath Singh slams Rahul Gandhi over ‘magician’ jibe at PM Modi
- Nashik TCS case: Absconding female accused to file for anticipatory bail, cites pregnancy
- Quote of the day by John F. Kennedy: “If we cannot end now our differences, at least we can help make the world safe for diversity. For, in the final analysis, our most basic common link is that we all inhabit this small planet. We all breathe the same air. We all cherish our children’s future. And we are all mortal.”
- Rupee hits one-week high as RBI moves to stem in fall
- ‘Centre trying to bypass OBCs and Dalits’: Rahul Gandhi slams centre over delimitation bill in Lok Sabha – top quotes
- UK man’s Marvel obsession stuns the world with over 60 tattoo comic masterpieces, securing the Guinness World Record title
UAE introduces first-ever weight loss pill Foundayo, here’s how much it may cost and where to get it
By
Add A Comment